SARS–CoV–2–specific CD4+ T cells are likely important in immunity against COVID–19, but our understanding of CD4+ longitudinal dynamics following infection, and specific features that correlate with the maintenance of neutralizing antibodies, remains limited. We characterized SARS–CoV–2–specific CD4+ T cells in a longitudinal cohort of 109 COVID–19 outpatients. The quality of the SARS–CoV–2–specific CD4+ response shifted from cells producing IFNγ to TNFα from five days to four months post–enrollment, with IFNγ−IL21−TNFα+ CD4+ T cells the predominant population detected at later timepoints. Greater percentages of IFNγ−IL21−TNFα+ CD4+ T cells on day 28 correlated with SARS–CoV–2 neutralizing antibodies measured seven months post–infection (ρ=0.4, P=0.01). mRNA vaccination following SARS–CoV–2 infection boosted both IFNγ and TNFα producing, spike protein–specific CD4+ T cells. These data suggest that SARS–CoV–2–specific, TNFα–producing CD4+ T cells may play an important role in antibody maintenance following COVID–19.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.